APOLLO ENDOSURGERY INC (APEN) Stock Overview
USA - NASDAQ:APEN - US03767D1081 - Common Stock
APEN Key Statistics, Chart & Performance
The current stock price of APEN is 10 USD. In the past month the price increased by 0.5%. In the past year, price increased by 65.56%.
APEN Latest News, Press Relases and Analysis
APEN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.42 | 220.78B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.47 | 195.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.27 | 149.82B | ||
| SYK | STRYKER CORP | 29.71 | 145.96B | ||
| MDT | MEDTRONIC PLC | 16.94 | 120.15B | ||
| BDX | BECTON DICKINSON AND CO | 13.02 | 53.26B | ||
| IDXX | IDEXX LABORATORIES INC | 53.36 | 51.27B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.61 | 44.68B | ||
| RMD | RESMED INC | 27.17 | 37.87B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.77 | 35.68B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.26 | 27.76B | ||
| DXCM | DEXCOM INC | 41.37 | 27.58B |
Related stock screener links
About APEN
Company Profile
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. The company is headquartered in West Lake Hills, Texas and currently employs 107 full-time employees. The company went IPO on 2005-04-21. The firm develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The firm's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.
Company Info
APOLLO ENDOSURGERY INC
1120 S Capital of Texas Hwy Bldg 1 Ste 300
West Lake Hills TEXAS 78746 US
CEO: Todd Newton
Employees: 107
Phone: 15122795100.0
APOLLO ENDOSURGERY INC / APEN FAQ
Can you describe the business of APOLLO ENDOSURGERY INC?
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. The company is headquartered in West Lake Hills, Texas and currently employs 107 full-time employees. The company went IPO on 2005-04-21. The firm develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The firm's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.
Can you provide the latest stock price for APOLLO ENDOSURGERY INC?
The current stock price of APEN is 10 USD. The price increased by 0.81% in the last trading session.
What is the dividend status of APOLLO ENDOSURGERY INC?
APEN does not pay a dividend.
What is the ChartMill rating of APOLLO ENDOSURGERY INC stock?
APEN has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is APEN stock listed?
APEN stock is listed on the Nasdaq exchange.
Can you provide the market cap for APOLLO ENDOSURGERY INC?
APOLLO ENDOSURGERY INC (APEN) has a market capitalization of 475.49M USD. This makes APEN a Small Cap stock.
APEN Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to APEN. When comparing the yearly performance of all stocks, APEN is one of the better performing stocks in the market, outperforming 96.28% of all stocks.
APEN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to APEN. Both the profitability and financial health of APEN have multiple concerns.
APEN Financial Highlights
Over the last trailing twelve months APEN reported a non-GAAP Earnings per Share(EPS) of -0.98. The EPS decreased by -9.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 1.04 |
APEN Forecast & Estimates
11 analysts have analysed APEN and the average price target is 10.2 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 10.
For the next year, analysts expect an EPS growth of 13.1% and a revenue growth 18.29% for APEN